v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   8,046    
Beginning balance at Dec. 31, 2024 $ 34,120 $ 1 $ 237,029 $ (202,910)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,523   1,523  
Issuance of common stock for vesting of restricted stock units (in shares)   98    
Shares withheld related to net share settlement of stock-based awards (in shares)   (42)    
Shares withheld related to net share settlement of stock-based awards (140)   (140)  
Net Income (Loss) (10,161)     (10,161)
Ending balance (in shares) at Mar. 31, 2025   8,102    
Ending balance at Mar. 31, 2025 25,342 $ 1 238,412 (213,071)
Beginning balance (in shares) at Dec. 31, 2024   8,046    
Beginning balance at Dec. 31, 2024 34,120 $ 1 237,029 (202,910)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net Income (Loss) (17,648)      
Ending balance (in shares) at Jun. 30, 2025   8,393    
Ending balance at Jun. 30, 2025 18,881 $ 1 239,438 (220,558)
Beginning balance (in shares) at Mar. 31, 2025   8,102    
Beginning balance at Mar. 31, 2025 25,342 $ 1 238,412 (213,071)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,574   1,574  
Issuance of common stock for vesting of restricted stock units (in shares)   449    
Shares withheld related to net share settlement of stock-based awards (in shares)   (158)    
Shares withheld related to net share settlement of stock-based awards (548)   (548)  
Net Income (Loss) (7,487)     (7,487)
Ending balance (in shares) at Jun. 30, 2025   8,393    
Ending balance at Jun. 30, 2025 $ 18,881 $ 1 239,438 (220,558)
Beginning balance (in shares) at Dec. 31, 2025 11,403 11,403    
Beginning balance at Dec. 31, 2025 $ 23,961 $ 1 252,026 (228,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 2,119   2,119  
Issuance of common stock for vesting of restricted stock units (in shares)   898    
Shares withheld related to net share settlement of stock-based awards (in shares)   (318)    
Shares withheld related to net share settlement of stock-based awards (663)   (663)  
Net Income (Loss) (4,916)     (4,916)
Ending balance (in shares) at Mar. 31, 2026   11,983    
Ending balance at Mar. 31, 2026 $ 20,501 $ 1 253,482 (232,982)
Beginning balance (in shares) at Dec. 31, 2025 11,403 11,403    
Beginning balance at Dec. 31, 2025 $ 23,961 $ 1 252,026 (228,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net Income (Loss) $ (11,809)      
Ending balance (in shares) at Jun. 30, 2026 14,146 14,146    
Ending balance at Jun. 30, 2026 $ 22,857 $ 2 262,730 (239,875)
Beginning balance (in shares) at Mar. 31, 2026   11,983    
Beginning balance at Mar. 31, 2026 20,501 $ 1 253,482 (232,982)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,988   1,988  
Issuance of common stock for vesting of restricted stock units (in shares)   860    
Shares withheld related to net share settlement of stock-based awards (in shares)   (167)    
Shares withheld related to net share settlement of stock-based awards (375)   (375)  
Issuance of common stock in at-the-market offering, net (in shares)   379    
Issuance of common stock in at-the-market offering, net 2,248   2,248  
Issuance of common stock in registered direct offering, net (In share)   1,091    
Issuance of common stock in registered direct offering, net 5,388 $ 1 5,387  
Net Income (Loss) $ (6,893)     (6,893)
Ending balance (in shares) at Jun. 30, 2026 14,146 14,146    
Ending balance at Jun. 30, 2026 $ 22,857 $ 2 $ 262,730 $ (239,875)